Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2−/− mice
| dc.contributor.author | Wang, Renxue | |
| dc.contributor.author | Sheps, Jonathan A. | |
| dc.contributor.author | Liu, Lin | |
| dc.contributor.author | Han, Jun | |
| dc.contributor.author | Chen, Patrick S. K. | |
| dc.contributor.author | Lamontagne, Jason | |
| dc.contributor.author | Wilson, Peter D. | |
| dc.contributor.author | Welch, Ian | |
| dc.contributor.author | Borchers, Christoph H. | |
| dc.contributor.author | Ling, Victor | |
| dc.date.accessioned | 2021-01-29T19:07:57Z | |
| dc.date.available | 2021-01-29T19:07:57Z | |
| dc.date.copyright | 2019 | en_US |
| dc.date.issued | 2019 | |
| dc.description.abstract | Bile acid imbalance causes progressive familial intrahepatic cholestasis type 2 (PFIC2) or type 3 (PFIC3), severe liver diseases associated with genetic defects in the biliary bile acid transporter bile salt export pump (BSEP; ABCB11) or phosphatidylcholine transporter multidrug resistance protein 3 (MDR3; ABCB4), respectively. Mdr2−/− mice (a PFIC3 model) develop progressive cholangitis, ductular proliferation, periportal fibrosis, and hepatocellular carcinoma (HCC) because the nonmicelle-bound bile acids in the bile of these mice are toxic. We asked whether the highly hydrophilic bile acids generated by Bsep−/− mice could protect Mdr2−/− mice from progressive liver damage. We generated double-KO (DKO: Bsep−/− and Mdr2−/−) mice. Their bile acid composition resembles that of Bsep−/− mice, with increased hydrophilic muricholic acids, tetrahydroxylated bile acids (THBAs), and reduced hydrophobic cholic acid. These mice lack the liver pathology of their Mdr2−/− littermates. The livers of DKO mice have gene expression profiles very similar to Bsep−/− mice, with 4,410 of 6,134 gene expression changes associated with the Mdr2−/− mutation being suppressed. Feeding with THBAs partially alleviates liver damage in the Mdr2−/− mice. Hydrophilic changes to biliary bile acid composition, including introduction of THBA, can prevent the progressive liver pathology associated with the Mdr2−/− (PFIC3) mutation. | en_US |
| dc.description.reviewstatus | Reviewed | en_US |
| dc.description.scholarlevel | Faculty | en_US |
| dc.identifier.citation | Wang, R., Sheps, J. A., Liu, L., Han, J., Chen, P. S. K., Borchers, C. H., … Ling, V. (2019). Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2−/− mice. Journal of Lipid Research, 60(1), 85-97. https://doi.org/10.1194/jlr.M088070. | en_US |
| dc.identifier.uri | https://doi.org/10.1194/jlr.M088070 | |
| dc.identifier.uri | http://hdl.handle.net/1828/12624 | |
| dc.language.iso | en | en_US |
| dc.publisher | Journal of Lipid Research | en_US |
| dc.subject | bile acids and salts/biosynthesis | |
| dc.subject | cancer | |
| dc.subject | gene expression | |
| dc.subject | hepatic cellular carcinoma | |
| dc.subject | hydrophobicity | |
| dc.subject | inflammation | |
| dc.subject | liver fibrosis | |
| dc.subject | progressive familial intrahepatic cholestasis | |
| dc.subject | tetrahydroxylated bile acids | |
| dc.subject | UVic Genome BC Proteomics Centre | |
| dc.subject.department | Department of Biochemistry and Microbiology | |
| dc.title | Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2−/− mice | en_US |
| dc.type | Article | en_US |